How will Hindustan Unilever Ltd benefit from the acquisition of GlaxoSmithKline Consumer Healthcare Limited?

How will Hindustan Unilever Ltd benefit from the acquisition of GlaxoSmithKline Consumer Healthcare Limited?

HUL will unlock significant synergies both from revenue and costs. As shared earlier, HUL will be partnering with GSK (via a consignment selling arrangement) to distribute brands of the GSK Consumer Healthcare family in India. This partnership, with world class brands from GSK (like Eno, Crocin, Sensodyne etc.)

How much did Unilever pay for Horlicks?

The giant has been buckling down on the growing beauty industry and nutrition markets. Consumer goods giant Unilever has today completed the acquisition of Horlicks and other Glaxosmithkline brands in a £397m deal.

Why did HUL buy Horlicks?

HUL paid GSK $398 million (₹30.5bn) more to buy Horlicks for the Indian market. And Unilever, HUL’s British-Dutch parent company, too paid around $54 million (₹4.15bn) to sell Horlicks in other countries….HUL to become the biggest food company in India.

READ ALSO:   Does hormone therapy help with weight loss?
Food companies Turnover (₹ crore) FY20E
Britannia ₹11532
ITC ₹10935

Is Horlicks under Unilever?

Today, Hindustan Unilever (HUL), our Indian listed subsidiary and the country’s largest fast-moving consumer goods company, merged with GSK Consumer Healthcare Limited in India. The GSK portfolio includes the hugely popular Horlicks and Boost brands – Horlicks commands a volume market share of around 50\% in India.

Is Horlicks a GSK product?

GSK today announced the completion of its divestment of Horlicks and other Consumer Healthcare nutrition products in India to Unilever, including the merger of its Indian listed entity, GlaxoSmithKline Consumer Healthcare Limited (“GSK India”), and Hindustan Unilever Limited (“HUL”).

Is GSK owned by HUL?

In early April, GSK received HUL’s shares in return of the sale of its Indian consumer business, GlaxoSmithKline Consumer Healthcare Ltd, to HUL. The two multinational giants had announced the all-share deal worth ₹31,700 crore ($3.8 billion) in December 2018.

Is GSK acquired by HUL?

READ ALSO:   Can dry ice be colder than?

In December, 2018, GlaxoSmithKline Consumer Healthcare Limited (GSK India) decided to merge with Hindustan Unilever Limited (HUL) and the equity merger deal was concluded in April, 2020.

Who purchased Horlicks?

Hindustan Unilever Ltd
HUL-GSK merger complete, FMCG giant buys Horlicks brand for ₹3,045 crore. NEW DELHI : Hindustan Unilever Ltd (HUL) has completed the merger of GlaxoSmithKline Consumer Healthcare Limited (GSKCH) with itself, over a year after the Rs31,700 crore mega-deal was first announced.

Who is the owner of Horlicks company?

SmithKline Beecham
Smithkline Beecham Legacy H Limited/Parent organizations

When did HUL acquired Horlicks?

December 2018
As per the deal announced in December 2018, the Horlicks brand, owned by GSK Plc, was acquired by parent Unilever and HUL would have to pay royalty for its use in India.

Why did Unilever buy Horlicks?

Nitin Paranjpe, President, Food & Refreshment, Unilever, said: “The iconic Horlicks brand has a deep heritage, credibility and resonance around the world. The acquisition is transformative for our Foods and Refreshment business allowing us to enter the Health Foods Drinks category, further strengthening our position in health and wellness.

READ ALSO:   Why is America an individualistic society?

Is Horlicks owned by GSK?

In the UK Horlicks was sold to Aimia Foods, which is part of the Cott Corporation. British pharmaceutical group GSK says India is still an important market and the company will concentrate on investing in its OTC and Oral Health brands, which include analgesic Crocin, antacid Eno and toothpaste Sensodyne.

What does Unilever’s acquisition of GlaxoSmithKline mean for the Indian market?

Pic:getty/omersukrugoksu Unilever will acquire GlaxoSmithKline’s Health Food Drinks portfolio in Asia for €3.3bn ($3.8bn): a move that will boost its presence in the Indian market.

What does the merger of GSK India with HUL mean for investors?

The proposed transaction involves the merger of GSK India with HUL, a public company listed on the NSE and BSE, following which GSK will own approximately 5.7\% of HUL. The merger values GSK India at INR317 billion in total, or INR7,540 per share, a 15.4\% premium to the un-disturbed share price of INR6,531 as at close of business on 26 March 2018.